In this study, we aim to investigate the expression of CKLF like MARVEL transmembrane domain containing 6 (CMTM6) in leukemia cells of patients with acute myeloid leukemia (AML). We will use peripheral blood samples and assess CMTM6 expression by flow cytometry and Western Blot.

Inclusion Criteria:

• age ≥ 18 years
• primary diagnosis of acute myeloid leukemia
• diagnosis results available
• written informed consent
• ability to understand the nature of the study and the study related procedures and to comply with them

Exclusion Criteria:

• age < 18 years
• lack of informed consent

Patients with AML at primary diagnosis ≥ 18 years of age

or

healthy probands ≥ 18 years of age